Chiron Capital Management’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$998K Sell
12,311
-3,398
-22% -$262K 0.85% 35
2025
Q2
$984K Buy
15,709
+1,403
+10% +$83K 0.86% 39
2025
Q1
$1.03M Buy
14,306
+5,298
+59% +$431K 0.94% 32
2024
Q4
$775K Sell
9,008
-4,101
-31% -$408K 0.73% 36
2024
Q3
$1.24M Buy
13,109
+1,100
+9% +$97.7K 1.1% 19
2024
Q2
$1.15M Buy
12,009
+1,099
+10% +$131K 1.1% 23
2024
Q1
$1.44M Buy
10,910
+8,310
+320% +$1.02M 1.31% 17
2023
Q4
$376K Buy
+2,600
New +$357K 0.33% 75
2020
Q4
Sell
-500
Closed -$45K 92
2020
Q3
$45K Buy
+500
New +$44.3K 0.04% 160

Other funds holding ALB

Chiron Capital Management's ALB Position: Q3 2025 in Review

Chiron Capital Management reduced its Albemarle (ALB) stake by 22% in Q3 2025, selling an estimated $262K and leaving 12,311 shares worth $998K. The position accounts for 0.85% of the portfolio, ranked #35.

Chiron Capital Management first reported a position in ALB in Q3 2020 and has held it in 9 quarters since. The position peaked at $1.44M in Q1 2024. 766 funds tracked by Wall St. Rank hold ALB as of Q3 2025.

  • Chiron Capital Management held 12,311 shares of Albemarle worth $998K as of Q3 2025.
  • Chiron Capital Management sold 3,398 Albemarle shares in Q3 2025, an estimated $262K.
  • Albemarle made up 0.85% of Chiron Capital Management's portfolio in Q3 2025, its #35 holding.
  • Chiron Capital Management first reported a position in Albemarle in Q3 2020 and has held it in 9 quarters since.
  • Chiron Capital Management's Albemarle position peaked at $1.44M in Q1 2024.
  • 766 funds tracked by Wall St. Rank held Albemarle as of Q3 2025.

Based on Chiron Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.